World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
39105
World Ranking
1232
National Ranking
642

Medicine

D-Index
86
Citations
39088
World Ranking
13893
National Ranking
7053

Robert W. Coombs publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert W. Coombs sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 323 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert W. Coombs D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert W. Coombs sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 86 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert W. Coombs is affiliated with the University of Washington in the United States. Their research primarily focuses on medicine, with a significant emphasis on infectious diseases, virology, and epidemiology. Additional subfields include neurology and emergency medicine.

The scientist's work encompasses a range of topics related to viral infections and treatments, especially in the context of HIV and COVID-19. Major research themes include SARS-CoV-2 and COVID-19 research, HIV research and treatment, COVID-19 clinical research studies, HIV/AIDS research and interventions, SARS-CoV-2 detection and testing, HIV/AIDS drug development and treatment, and respiratory viral infections research.

Recent papers authored or coauthored by Robert W. Coombs include:

  • Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico, 2021, New England Journal of Medicine
  • A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus, 2021, Science Translational Medicine
  • A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir, 2021, Cell Reports Medicine
  • Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies, 2021, Clinical Infectious Diseases
  • Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance, 2020, Journal of Clinical Virology

The frequent coauthors collaborating with Robert W. Coombs are:

  • Joseph J. Eron
  • Eric S. Daar
  • David A. Wohl
  • Jonathan Z. Li
  • Davey M. Smith

Most publications have appeared in the following venues:

  • UNC Libraries
  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases

Best Publications

  • Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

    Edward M. Connor;Rhoda S. Sperling;Richard Gelber;Pavel Kiselev

  • Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

    Jared M. Baeten;Deborah Donnell;Deborah Donnell;Patrick Ndase;Nelly R. Mugo;Nelly R. Mugo

  • Reduction of maternal-infant transmission of human immunodeficiency virus 1 with zidovudine treatment

    Edward M. Connor;Rhoda S. Sperling;Richard Gelber;Pavel Kiselev

  • Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

    Ann C. Collier;Robert W. Coombs;David A. Schoenfeld;Roland L. Bassett

  • Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant

    Rhoda S. Sperling;David E. Shapiro;Robert W. Coombs;John A. Todd

  • Plasma Viremia in Human Immunodeficiency Virus Infection

    Robert W. Coombs;Ann C. Collier;Jean-P. Allain;Beverly Nikora

  • HIV viral load markers in clinical practice

    M S Saag;M Holodniy;D R Kuritzkes;W A O'Brien

  • Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

    Ginger Lehrman;Ian B Hogue;Sarah Palmer;Cheryl Jennings

  • Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

    Unknown

  • Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

    C. Celum;A. Wald;A. Wald;J.R. Lingappa;A.S. Magaret;A.S. Magaret

  • Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type.

    William E. Lafferty;Robert W. Coombs;Jacqueline Benedetti;Cathy Critchlow

  • A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

    Unknown

  • Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study

    Renee Heffron;Deborah Donnell;Helen Rees;Connie Celum

  • Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

    E. L. Cooney;E. L. Cooney;E. L. Cooney;A. C. Collier;A. C. Collier;A. C. Collier;P. D. Greenberg;P. D. Greenberg;P. D. Greenberg;R. W. Coombs;R. W. Coombs;R. W. Coombs

  • Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection

    Craig W. Hendrix;Ann C. Collier;Michael Marcel Lederman;Dominique Schols

  • Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

    Christina M. Marra;Yu Zhao;David B. Clifford;Scott Letendre

  • Biological and virologic characteristics of primary HIV infection.

    Timothy W. Schacker;James P. Hughes;Theresa Shea;Robert W. Coombs

  • Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model.

    Hrishikesh Chakraborty;Pranab K. Sen;Ronald W. Helms;Pietro L. Vernazza

  • Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission

    Jared M. Baeten;Erin Kahle;Jairam R. Lingappa;Robert W. Coombs

  • Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission.

    Seymour J. Klebanoff;Robert W. Coombs

  • Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy

    Richard T. D'Aquila;Victoria A. Johnson;Seth L. Welles;Anthony J. Japour

  • Recent observations on HIV type-1 infection in the genital tract of men and women.

    Robert W Coombs;Patricia S Reichelderfer;Alan L Landay

  • Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

    Ian C. Marschner;Ann C. Collier;Robert W. Coombs;Richard T. D'Aquila

  • Association between Culturable Human Immunodeficiency Virus Type 1 (HIV-1) in Semen and HIV-1 RNA Levels in Semen and Blood: Evidence for Compartmentalization of HIV-1 between Semen and Blood

    Robert W. Coombs;Carl E. Speck;James P. Hughes;Willa Lee

  • Isolation of Human Immunodeficiency Virus from Genital Ulcers in Nairobi Prostitutes

    Joan K. Kreiss;Robert Coombs;Francis Plummer;King K. Holmes

Frequent Co-Authors

Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Lisa M. Frenkel
Lisa M. Frenkel University of Washington
Ann C. Collier
Ann C. Collier University of Washington
Connie Celum
Connie Celum University of Washington
Elizabeth A. Bukusi
Elizabeth A. Bukusi University of Washington
Jared M. Baeten
Jared M. Baeten University of Washington
James I. Mullins
James I. Mullins University of Washington
Allan R. Ronald
Allan R. Ronald University of Manitoba
John N. Krieger
John N. Krieger University of Washington
Anna Wald
Anna Wald University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise after studying Immunology in the USA, pursuing related online degrees can open diverse career pathways. Nursing professionals, for instance, can explore 12-month accelerated nursing programs online for non nurses, which offer a fast-track entry into the nursing field, ideal for career changers looking to integrate immunology knowledge with patient care.

Advancing to specialized roles such as nurse practitioners is another popular option. Many candidates consider accelerated nurse practitioner programs that provide condensed curricula designed to prepare nurses efficiently for advanced clinical responsibilities.

For those already working as Family Nurse Practitioners (FNPs), seamless transitions to acute care are available through programs like the fnp to acnp bridge program online. This pathway enhances clinical skills in critical care settings, expanding career opportunities.

When considering financial prospects, it’s important to reference the how much does a dnp make guide, which analyzes salary variations by state for those holding a Doctor of Nursing Practice degree. Such information helps in making informed decisions about education investments and career planning.

Best Scientists Citing Robert W. Coombs

Trending Scientists

Recently Published Articles